BlackRock’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-287,565
| Closed | -$10.4K | – | 5431 |
|
|
2024
Q1 | $10.4K | Sell |
287,565
-1,697
| -0.6% | -$580 | ﹤0.01% | 5083 |
|
|
2023
Q4 | $119K | Buy |
289,262
+68,387
| +31% | +$38.6K | ﹤0.01% | 4762 |
|
|
2023
Q3 | $228K | Buy |
220,875
+27,150
| +14% | +$34.7K | ﹤0.01% | 4640 |
|
|
2023
Q2 | $374K | Buy |
193,725
+41,316
| +27% | +$71.1K | ﹤0.01% | 4569 |
|
|
2023
Q1 | $123K | Buy |
152,409
+24,543
| +19% | +$35.9K | ﹤0.01% | 4909 |
|
|
2022
Q4 | $165K | Sell |
127,866
-331,817
| -72% | -$525K | ﹤0.01% | 4903 |
|
|
2022
Q3 | $731K | Buy |
459,683
+10,092
| +2% | +$23K | ﹤0.01% | 4593 |
|
|
2022
Q2 | $797K | Buy |
449,591
+98,722
| +28% | +$251K | ﹤0.01% | 4624 |
|
|
2022
Q1 | $1.46M | Sell |
350,869
-13,018
| -4% | -$43.6K | ﹤0.01% | 4523 |
|
|
2021
Q4 | $924K | Buy |
363,887
+2,128
| +0.6% | +$7.01K | ﹤0.01% | 4695 |
|
|
2021
Q3 | $1.42M | Buy |
361,759
+15,761
| +5% | +$78.8K | ﹤0.01% | 4461 |
|
|
2021
Q2 | $2.22M | Sell |
345,998
-168,714
| -33% | -$1.16M | ﹤0.01% | 4227 |
|
|
2021
Q1 | $4.16M | Buy |
514,712
+75,318
| +17% | +$691K | ﹤0.01% | 4021 |
|
|
2020
Q4 | $3.69M | Buy |
439,394
+429,860
| +4,509% | +$2.91M | ﹤0.01% | 3822 |
|
|
2020
Q3 | $40K | Hold |
9,534
| – | – | ﹤0.01% | 4634 |
|
|
2020
Q2 | $44K | Buy |
9,534
+7,895
| +482% | +$36.2K | ﹤0.01% | 4598 |
|
|
2020
Q1 | $5K | Buy |
+1,639
| New | +$6.95K | ﹤0.01% | 4782 |
|
Other funds holding GMDA
BlackRock's GMDA Position: Q2 2024 in Review
BlackRock sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q2 2024, closing a stake of 287,565 shares — an estimated $10.4K sold.
BlackRock first reported a position in GMDA in Q1 2020 and held it in 17 quarters. The position peaked at $4.16M in Q1 2021. 2 funds tracked by Wall St. Rank hold GMDA as of Q2 2024.
- BlackRock reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q2 2024 after selling out during the quarter.
- BlackRock sold 287,565 Gamida Cell Ltd. Ordinary Shares shares in Q2 2024, an estimated $10.4K.
- BlackRock first reported a position in Gamida Cell Ltd. Ordinary Shares in Q1 2020 and held it in 17 quarters.
- BlackRock's Gamida Cell Ltd. Ordinary Shares position peaked at $4.16M in Q1 2021.
- 2 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q2 2024.
Based on BlackRock's 13F filing for Q2 2024, filed 13 Aug 2024.